Experience in managing a patient with rheumatoid arthritis and pulmonary manifestations (clinical case)
The article describes a clinical case of observation and treatment of a patient with a primary reason for treatment for lung disease. However, in the course of additional examination, observation and joint work of doctors of different specialties, the diagnosis was clarified, rheumatoid arthritis (RA) with systemic manifestations was revealed – this is a chronic autoimmune disease with articular and extraarticular manifestations of unknown etiology. Hereditary predisposition and environmental factors play an important role in the development of arthritis. The dynamics of the patient's clinical state and the applied approaches to treatment are described. Changes in computed tomography data for several years of observation are presented and discussed. Such situations often cause significant difficulties in the work of primary care specialists, often the diagnosis remains incorrect or unclear for a long time, which affects the tactics and effectiveness of treatment. In addition, this disease is often the cause of disability. Moreover, the prevalence of RA is about 1 %. The description of this case can be useful in the work of doctors of different specialties - therapists, pulmonologists, rheumatologists, GPs, etc.
Bontsevich R.A., Solovyova L.V., Shirokaya M.A., Solyanova N.A., Shchurovskaya K.V., Mikhno A.V.2021. Experience in managing a patient with rheumatoid arthritis and pulmonary manifestations (clinical case). Challenges in modern medicine. 44 (1): 38–48 (in Russian).
While nobody left any comments to this publication.
You can be first.
Il'kovich M.M. 2011. Disseminirovannye zabolevanija legkih [Disseminated lung disease]. Moskva: GJeOTAR-Media; 480 s.
Cvetkova O.A., Varshavskij V.A., Fominyh E.V., Kolosova K.Ju., Mustafina M.H., Bujanova O.E. 2011. Redkij variant porazhenija legkih pri revmatoidnom artrite [A rare variant of lung damage in rheumatoid arthritis]. Pul'monologija. 5: 113–118. https://doi.org/10.18093/0869-0189-2011-0-5-113-118.
Atzeni F., Talotta R., Masala I.F., Bongiovanni S., Boccassini L., Sarzi-Puttini P. 2017. Biomarkers in Rheumatoid Arthritis. Isr. Med. Assoc. J. Aug; 19 (8): 512–516. PMID: 28825772. https://pubmed.ncbi.nlm.nih.gov/28825772/.
Choi S., Lee K.H. 2018. Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study. PLoS One. Apr 6; 13 (4): e0195550. doi: 10.1371/journal.pone.0195550. Erratum in: PLoS One. 2018 Jun 18; 13(6) :e0199468. PMID: 29624625; PMCID: PMC5889180. https://pubmed.ncbi.nlm.nih.gov/29624625/.
Croia C., Bursi R., Sutera D., Petrelli F., Alunno A., Puxeddu I. 2019. One year in review 2019: pathogenesis of rheumatoid arthritis. Clin. Exp. Rheumatol. May-Jun; 37 (3): 347–357. Epub 2019 May 10. PMID: 31111823. https://pubmed.ncbi.nlm.nih.gov/31111823/.
Deane K.D., Demoruelle M.K., Kelmenson L.B., Kuhn K.A., Norris J.M., Holers V.M. 2017. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 31 (1): 3–-18. doi: 10.1016/j.berh.2017.08.003. Epub 2017 Sep 18. PMID: 29221595; PMCID: PMC5726551. https://pubmed.ncbi.nlm.nih.gov/29221595/.
Esposito A.J., Chu S.G., Madan R., Doyle T.J., Dellaripa P.F. 2019. Thoracic Manifestations of Rheumatoid Arthritis. Clin. Chest. Med. 40 (3): 545–560. doi: 10.1016/j.ccm.2019.05.003. Epub 2019 Jul 6. PMID: 31376890; PMCID: PMC6994971. https://pubmed.ncbi.nlm.nih.gov/31376890/.
Marcucci E., Bartoloni E., Alunno A., Leone M.C., Cafaro G., Luccioli F., Valentini V., Valentini E., La Paglia G.M.C., Bonifacio A.F., Gerli R. 2018. Extra-articular rheumatoid arthritis. Reumatismo. 20; 70 (4): 212–224. doi: 10.4081/reumatismo.2018.1106. PMID: 30570239. https://pubmed.ncbi.nlm.nih.gov/30570239/.
Nehring S.M., Goyal A., Bansal P., Patel B.C. C Reactive Protein. 2020. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. PMID: 28722873. https://pubmed.ncbi.nlm.nih.gov/28722873/.
Nikiphorou E., de Lusignan S., Mallen C., Roberts J., Khavandi K., Bedarida G., Buckley C.D., Galloway J., Raza K. 2020. Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study. Rheumatology (Oxford).59 (6): 1296–1305. doi: 10.1093/rheumatology/kez409. PMID: 31580449; PMCID: PMC7244778. https://pubmed.ncbi.nlm.nih.gov/31580449/.
Paulin F., Mercado J.F., Fernández M.E., Caro F.M., Alberti M.L., Fassola L.A. 2018. Correlation between Lung and Joint Involvement in Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Cross-Sectional Study. Rev. Invest. Clin. 70 (2): 76–81. doi: 10.24875/RIC.18002474. PMID: 29718008. https://pubmed.ncbi.nlm.nih.gov/29718008/.
Salaffi F., Carotti M., Di Carlo M., Tardella M., Giovagnoni A. 2019. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities. Medicine (Baltimore). 98 (38): e17088. doi: 10.1097/MD.0000000000017088. PMID: 31567944; PMCID: PMC6756733. https://pubmed.ncbi.nlm.nih.gov/31567944/.
Taylor P.C. 2020. Update on the diagnosis and management of early rheumatoid arthritis. Clin. Med. (Lond). Nov; 20 (6): 561–564. doi: 10.7861/clinmed.2020-0727. PMID: 33199320; PMCID: PMC7687323. https://pubmed.ncbi.nlm.nih.gov/33199320/.
Viatte S., Barton A. 2017. Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. Semin Immunopathol. 39 (4): 395–408. doi: 10.1007/s00281-017-0630-4. Epub 2017 May 29. PMID: 28555384; PMCID: PMC5486781. https://pubmed.ncbi.nlm.nih.gov/28555384/.
Wasserman A. 2018. Rheumatoid Arthritis: Common Questions About Diagnosis and Management. Am. Fam. Physician. 97 (7): 455–462. PMID: 29671563. https://pubmed.ncbi.nlm.nih.gov/29671563/.